semaglutide tablets patent expiry New weight-loss drugs and to impact pharma in 2026 | Business Today posted on the topic No Semaglutide Generics Approved in

The honest answer: Retatrutide looks more powerful on headline weight-loss potential, but there is no true head-to-head trial against CagriSema yet

But, she said, its often easier said than done

Body Balance Medical offers medically supervised GLP-1 weight loss programs in Las Vegas, with in-person provider oversight, dose titration, and lab monitoring built into every program

Join our newsletter for exclusive wellness tips, special offers, and updates

Why These Limitations Matter for Interpretation Taken together, the limitations mean GHRP-2 should be understood as a scientifically important and well-characterized research compound genuinely valuable for what it taught endocrinology about the ghrelin/GHS-R1a system, and genuinely useful as a diagnostic probe but not as a validated therapy